Newron Pharmaceuticals S.p.A.
NP5
Hisse Senetlerindeki Sıralama
#17696
Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in... Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in Bresso, Milano, with a dedicated team of 24 full-time employees. The company's core mission is the discovery and advancement of innovative pharmaceutical products, particularly focusing on new therapies for Central Nervous System (CNS) disorders and pain management. Among its leading candidates, safinamide is currently undergoing Phase III clinical trials for the treatment of Parkinson's disease. Additionally, ralfinamide is being developed as a potential therapy for neuropathic pain. The firm's pipeline further includes a range of projects at various preclinical and clinical development stages, such as HF0220 for neuroprotection, NW-3509 for schizophrenia, and pruvanserin and sarizotan for other CNS conditions.
Hisse Fiyatı
$10.40
Piyasa Değeri
$212.64M
Değişim (1 gün)
1.09%
Değişim (1 yıl)
-41.83%
Ülke
IT
Ticaret Newron Pharmaceuticals S.p.A. (NP5)
Kategori
Healthcare
Newron Pharmaceuticals S.p.A. (NP5) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $10.24 - 2026-10-01
Gün sonu en düşük fiyat: $31.91 - 2015-07-01
Gün sonu en düşük fiyat: $31.91 - 2015-07-01
Newron Pharmaceuticals S.p.A. için hisse fiyatı geçmişi: 2015 - 2026
Yıllık Hisse Fiyatı Performansı
| Yıl | Performans |
|---|---|
| 2026 (TTM) | -24.57% |
| 2025 | 182.46% |
| 2024 | 72.12% |
| 2023 | 283.57% |
| 2022 | -24.03% |
| 2021 | -24.86% |
| 2020 | -62.21% |
| 2019 | -18.66% |
| 2018 | -28.88% |
| 2017 | -55.22% |
| 2016 | -5.77% |
| 2015 | 0.00% |
Benzer şirketler veya rakiplerin hisse fiyatı
| Şirket | Hisse fiyatı | Değişim 1yıl% | Ülke |
|---|---|---|---|
| $536.74 | 25.87% |
US
|
|
| $227.23 | 746.28% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $881.75 | 8.30% |
NL
|
